Paper22784609
Role of antioxidants in cancer therapy.
Fuchs-Tarlovsky V. Nutrition, 2013. Cited by 174 papers, by iCite.
Cite this record
ConductScience Library. Role of antioxidants in cancer therapy. Papers, record 22784609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22784609
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Dietary Supplements | |
| Free Radicals | |
| Humans | |
| Models, Biological | |
| Oxidative Stress | |
| Reactive Oxygen Species |
Source PubMed
Cited by110
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 174 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42446675 | Chalcones as multitarget modulators in non-small cell lung cancer: mechanistic insights and therapeutic perspectives. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42446675 | PubMed |
| 42270788 | Controlled delivery of nilotinib using LDH/Fe2O3-modified chitosan nanocomposite hydrogel beads for the treatment of chronic myeloid leukemia. | Sci Rep | 2026 | https://conductscience.org/library/papers/42270788 | PubMed |
| 42162067 | Phytochemical profiling of Pleurospermum candollei flowers and stems reveals antioxidant constituents with topoisomerase II-targeted anticancer potential. | Sci Rep | 2026 | https://conductscience.org/library/papers/42162067 | PubMed |
| 41862889 | Anticancer potential of Curcuma caesia: induction of DNA damage and apoptosis in cervical cancer. | BMC Complement Med Ther | 2026 | https://conductscience.org/library/papers/41862889 | PubMed |
| 41331055 | Extraction process and antioxidant and antimicrobial activities of total flavonoids from Broussonetia papyrifera leaves. | Sci Rep | 2025 | https://conductscience.org/library/papers/41331055 | PubMed |
| 40854670 | Exploring the anticancer and antioxidant properties of Lagerstroemia speciosa bark extract via phytochemical and molecular docking analysis. | J Genet Eng Biotechnol | 2025 | https://conductscience.org/library/papers/40854670 | PubMed |
| 40720255 | Metabolic adaptations in cancer progression. | Physiol Rev | 2026 | https://conductscience.org/library/papers/40720255 | PubMed |
| 40542782 | Antioxidant property of Silver Nanoparticles Loaded with Alcoholic Extraction of Lycium Shawii. | Asian Pac J Cancer Prev | 2025 | https://conductscience.org/library/papers/40542782 | PubMed |
| 40430101 | Oxidative Stress, Inflammation, and Antioxidant Strategies in Cervical Cancer-A Narrative Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40430101 | PubMed |
| 39945263 | The Role of Nutraceuticals in Chemoprevention and their Therapeutic Effects when used in Combination with Synthetic Drugs. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39945263 | PubMed |
| 39866644 | Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulin. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39866644 | PubMed |
| 39769100 | Design, Synthesis, and Biological Evaluation of Novel Urea-Containing Carnosic Acid Derivatives with Anticancer Activity. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769100 | PubMed |
| 39484304 | Exploring Neuroprotection against Radiation-Induced Brain Injury: A Review of Key Compounds. | NeuroSci | 2024 | https://conductscience.org/library/papers/39484304 | PubMed |
| 39456769 | Traditional Medicinal Ranunculaceae Species from Romania and Their In Vitro Antioxidant, Antiproliferative, and Antiparasitic Potential. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39456769 | PubMed |
| 38790707 | Cellular ROS and Antioxidants: Physiological and Pathological Role. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38790707 | PubMed |
| 38602182 | Antiapoptotic PON2 expression and its clinical implications in locally advanced oral squamous cell carcinoma. | Cancer Sci | 2024 | https://conductscience.org/library/papers/38602182 | PubMed |
| 38542729 | Olive Oil Components as Novel Antioxidants in Neuroblastoma Treatment: Exploring the Therapeutic Potential of Oleuropein and Hydroxytyrosol. | Nutrients | 2024 | https://conductscience.org/library/papers/38542729 | PubMed |
| 38474594 | Revealing Novel Source of Breast Cancer Inhibitors from Seagrass Enhalus acoroides: In Silico and In Vitro Studies. | Molecules | 2024 | https://conductscience.org/library/papers/38474594 | PubMed |
| 38344286 | Exploration of bioactive compounds from Olea dioica in Western Ghats of Karnataka using GC-MS. | 3 Biotech | 2024 | https://conductscience.org/library/papers/38344286 | PubMed |
| 38264646 | Corrigendum: Immunomodulatory function and anti-tumor mechanism of natural polysaccharides: a review. | Front Immunol | 2023 | https://conductscience.org/library/papers/38264646 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22784609
GET https://conductscience.org/api/papers/v1/22784609/cited_by?page=2